Iridex
Laser-based medical systems provider IRIDEX Corporation has reportedly received two new patent approvals from the U.S. Patent Office for recent submissions regarding its TxCell Scanning Laser Delivery System.
The TxCell system is a platform that allows MicroPulse laser therapy to be planned and delivered in a grid pattern. This reportedly allows the procedure to be completed with greater efficiency and confidence than older "single-spot" delivery strategies.
IRIDEX received U.S. Patent No. 9,265,656 entitled "Grid Pattern Laser Treatment and Methods for Treating an Eye" and U.S. Patent No. 9,278,029 entitled "Short Duration Pulse Grid Pattern Laser Treatment and Methods." The patents expand on the core MicroPulse technology and cover automatic laser delivery with multi-spot pattern scanning for efficient retinal photocoagulation that is tissue sparing and enables faster treatment procedures.
Click here to read the full press release.